Regenerative Engineering And Translational Medicine
期刊中文名：再生工程與轉化醫學ISSN：2364-4133E-ISSN：2364-4141
該雜志國際簡稱：REGEN ENG TRANSL MED，是由出版商Springer Nature出版的一本致力于發布--研究新成果的的專業學術期刊。主要發表刊登有創見的學術論文文章、行業最新科研成果，扼要報道階段性研究成果和重要研究工作的最新進展，選載對學科發展起指導作用的綜述與專論，促進學術發展，為廣大讀者服務。該刊是一本國際優秀雜志，在國際上有很高的學術影響力。
雜志介紹
Regenerative Engineering And Translational Medicine雜志介紹
《Regenerative Engineering And Translational Medicine》是一本以English為主的未開放獲取國際優秀期刊，中文名稱再生工程與轉化醫學，本刊主要出版、報道領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.2，最新CiteScore 指數為4.9。
英文介紹
Regenerative Engineering And Translational Medicine雜志英文介紹
regenerative Engineering Is An International Journal Covering Convergence Of The Disciplines Of Tissue Engineering, Advanced Materials Science, Stem Cell Research, The Physical Sciences, And Areas Of Developmental Biology. This Convergence Brings Exciting Opportunities To Translate Bench-top Research Into Bedside Methods, Allowing The Possibility Of Moving Beyond Maintaining Or Repairing Tissues To Regenerating Them. The Journal Encourages Both Top-down Engineering Approaches And Bottom-up Strategies Integrating Materials Science With Stem Cell Research And Developmental Biology. Convergence Papers On Instructive Biomaterials, Stimuli-responsive Biomaterials, Micro- And Nano-patterning For Regenerative Engineering, Elastomeric Biomaterials, Hydrogels For Tissue Engineering, And Rapid Prototyping And Bioprinting Approaches Are Particularly Welcome.
The Journal Provides A Premier, Single-blind peer-reviewed Forum For The Publication Of Original Papers, Authoritative Reviews, Rapid Communications, News And Views, And Opinion Papers Addressing The Most Important Issues And Efforts Toward Successfully Regenerating Complex Human Tissues And Organs. All Research Articles Feature A Lay Abstract Highlighting The Relevance And Future Impact For Patients, Government And Other Health Officials, And Members Of The General Public. Bridging The Gap Between The Lab And The Clinic, The Journal Also Serves As A Dedicated Platform For Showcasing Translational Research That Brings Basic Scientific Research And Discoveries Into Clinical Methods And Therapies, Contributing To The Improvement Of Human Health Care.topics Covered In Regenerative Engineering And Translational Medicine include:advanced Materials Science For Regenerative And Biomedical Applicationsstem Cells For Tissue Regenerationdrug Delivery For Tissue Regenerationnanomaterials And Nanobiotechnology For Tissue Regenerationstudies Combining Tissue Engineering/regeneration With Developmental Biologyconvergence Research In Pre-clinical And Clinical Phases
JCR分區（2023-2024年最新版）
Regenerative Engineering And Translational Medicine雜志 JCR分區信息
| 按JIF指標學科分區 |
學科：ENGINEERING, BIOMEDICAL
收錄子集：ESCI
分區：Q3
排名：82 / 122
百分位：
33.2% |
| 按JCI指標學科分區 |
學科：ENGINEERING, BIOMEDICAL
收錄子集：ESCI
分區：Q4
排名：97 / 122
百分位：
20.9% |
JCR分區：JCR分區來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具，為唯一提供基于引文數據的統計信息的期刊評價資源。每年發布的JCR分區，設置了254個具體學科。JCR分區根據每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區，分別為Q1、Q2、Q3和Q4，各占25%。JCR分區中期刊的數量是均勻分為四個部分的。
CiteScore 評價數據（2024年最新版）
Regenerative Engineering And Translational Medicine雜志CiteScore 評價數據
- CiteScore 值：4.9
- SJR：0.487
- SNIP：0.513
| 學科類別 | 分區 | 排名 | 百分位 |
| 大類：Medicine 小類：Medicine (miscellaneous) | Q2 | 113 / 398 |
71% |
| 大類：Medicine 小類：Biomedical Engineering | Q2 | 135 / 303 |
55% |
| 大類：Medicine 小類：Biomaterials | Q3 | 73 / 137 |
47% |
| 大類：Medicine 小類：Cell Biology | Q3 | 195 / 285 |
31% |
歷年影響因子和期刊自引率
投稿經驗
Regenerative Engineering And Translational Medicine雜志投稿經驗
該雜志是一本國際優秀雜志，在國際上有較高的學術影響力，行業關注度很高，已被國際權威數據庫SCIE收錄，該雜志在綜合專業領域專業度認可很高，對稿件內容的創新性和學術性要求很高，作為一本國際優秀雜志，一般投稿過審時間都較長，投稿過審時間平均 ，如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單，建議您投稿。如您想了解更多投稿政策及投稿方案，請咨詢客服。
免責聲明
若用戶需要出版服務，請聯系出版商。